DPP-4 Inhibition on Top of Angiotensin Receptor Blockade Offers a New Therapeutic Approach for Diabetic Nephropathy-Reference-Cited by-同舟云学术

DPP-4 Inhibition on Top of Angiotensin Receptor Blockade Offers a New Therapeutic Approach for Diabetic Nephropathy

Published:2012 Issue:1 Volume:36 Page:119-130
ISSN:1423-0143
Container-title:Kidney and Blood Pressure Research
language:en
Short-container-title:Kidney Blood Press Res

Author:

Alter Markus L.,Ott Ina M.,von Websky Karoline,Tsuprykov Oleg,Sharkovska Yuliya,Krause-Relle Katharina,Raila Jens,Henze Andrea,Klein Thomas,Hocher Berthold

Publisher

S. Karger AG

Subject

Cardiology and Cardiovascular Medicine,Nephrology,Cardiology and Cardiovascular Medicine,Nephrology

Reference50 articles.

1. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

2. Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

3. A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study

4. Why blockade of the renin–angiotensin system reduces the incidence of new-onset diabetes

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Dipeptidyl Peptidase-4 Inhibitor and Angiotensin-Converting Enzyme Inhibitor on Experimental Diabetic Kidney Disease;Laboratory Investigation;2024-02

2. Diabetic Nephropathy: Pathogenesis and Drug Delivery System;Research Journal of Pharmacy and Technology;2023-12-29

3. Effect of Teneligliptin in comparison with Voglibose as an add on therapy in reducing microvascular complications in type II Diabetes Mellitus patients – A Prospective randomized control trial;Research Journal of Pharmacy and Technology;2023-12-29

4. Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease;Pharmaceutics;2023-07-01

5. Effektive antidiabetische Therapie zur Vorbeugung einer diabetischen Nephropathie;Nephrologie aktuell;2023-07